Human brain contains one cationic (pI8.3) and two anionic (pI5.5 and 4.6) forms of glutathione S-transferase. The cationic form (pI 8.3) and the less-anionic form (p1 5.5) do not correspond to any of the glutathione S-transferases previously characterized in human tissues. Both of these forms are dimers of 26 500-Mr subunits; however, immunological and catalytic properties indicate that these two enzyme forms are different from each other. The cationic form (pI8.3) cross-reacts with antibodies raised against cationic glutathione S-transferases of human liver, whereas the anionic form (pI5.5) does not. Additionally, only the cationic form expresses glutathione peroxidase activity. The other anionic form (pl 4.6) is a dimer of 24 500-Mr and 22 500-Mr subunits. Two-dimensional gel electrophoresis demonstrates that there are three types of 26 500-Mr subunits, two types of 24 500-Mr subunits and two types of 22 500-Mr subunits present in the glutathione S-transferases of human brain.
GSH S-transferases (EC 2.5.1.18) are a family of multifunctional enzymes that provide protection to organisms from the toxic effects of xenobiotics (Booth et al., 1961; Jakoby, 1978; Chasseaud, 1979) . These enzymes catalyse the conjugation of a large variety of xenobiotics with GSH (Booth et al., 1961; Chasseaud, 1979) . GSH S-transferases can also bind a wide group of ligands (Litwack et al., 1971; Jakoby, 1978) , and several forms of this enzyme express GSH peroxidase activity towards lipid hydroperoxides (Prohaska & Ganther, 1977; Pierce & Tappel, 1978; Awasthi et al.,'1980) .
In human tissues several forms of GSH S-transferases differing in isoelectric points and catalytic abilities have been described (Kamisaka et al., 1975; Marcus et al., 1978; Awasthi et al., 1980; Awasthi & Dao, 1981; Partridge et al., 1984) . It was previously suggested that five cationic forms present in human liver are homodimers of a single gene product, and that the charge heterogeneity of these forms is due to deamidation in ri;o (Kamisaka et al., 1975) . Subsequent investigations in this laboratory (Dao et al., 1982) , however, have demonstrated that at least two subunits, of Mr Abbreviation used: GSH, reduced glutathione.
* To whom correspondence should be addressed. 26500 and 24500, are present among the cationic GSH S-transferases of human liver. The presence of another subunit, of Mr 22500, has been demonstrated in the anionic GSH S-transferases of human liver, placenta and lung, and it has been suggested that at least three different constituent subunits in their binary combinations give rise to different forms of GSH S-transferase of human tissues Partridge et al., 1984) . Three subunits, however, do not account for the multitude of different GSH S-transferases that have been reported so far from human tissues, and the structural basis for the origin of different GSH S-transferases still remains to be explained.
In order to understand better the genetic and structural basis for the origin of different GSH Stransferases of human tissues, we have studied the structural, kinetic and immunochemical characteristics of three forms of GSH S-transferase present in human brain. These enzymes were purified to homogeneity, and their subunit structures, amino acid compositions and substrate specificities were studied. Using two-dimensional gel electrophoresis, we investigated the heterogeneity in the subunits having similar Mr values. Antibodies raised against purified GSH S-transferases of human liver, lung and placenta were used to inVol. 225 vestigate the immunological interrelationships among these enzymes.
Materials and methods

Materials
Human brain samples were obtained at autopsy, and were either processed immediately or frozen at -20°C. The sources of all chemicals used in this study were the same as those reported by us in previous studies Singh et al., 1984) . Antibodies raised against the cationic GSH S-transferases of liver and those raised against the anionic enzymes of lung and placenta were the same as those used by us previously .
Purification of human brain GSH S-transferases
All purification steps were performed at 4°C, and enzyme activity during the purification was monitored with 1-chloro-2,4-dinitrobenzene as the substrate. Brain tissue was cleaned, washed with distilled water and cut into small pieces. A 10% (w/v) homogenate was prepared in 10mM-potassium phosphate buffer, pH 7.0, containing 1.4mM-2-mercaptoethanol (buffer A) by using a Sorvall Omnimixer at 4000 rev./min. The homogenate was centrifuged at 16000g for 30min, and most of the GSH S-transferase activity was recovered in the supernatant. Solid (NH4)2SO4 was gradually added to the supernatant with constant stirring to bring about a final saturation of 80%; the pH was maintained at 7.0 throughout the addition. The mixture was stirred overnight and centrifuged at 16000g for 30min. The supernatant had negligible GSH S-transferase activity and was discarded. The pellet was resuspended in buffer A, and dialysed for 48 h against the same buffer (40 vol., four changes). After dialysis, the enzyme solution was centrifuged at 16000g for 2h and the supernatant was subjected to affinity chromatography over a column (1 cm x 10cm) of GSH-linked epoxy-activated Sepharose 6B (Simons & Vander Jagt, 1977) . The column was pre-equilibrated with 22mM-potassium phosphate buffer, pH7.0, containing 1.4mM-2-mercaptoethanol (buffer B) at a flow rate of 10ml/h. After application of the enzyme, the column was washed thoroughly with buffer B until the eluate had no absorbance at 280nm. The enzyme was eluted with 10mM-GSH in 50mM-Tris/HCl buffer, pH9.6, and was dialysed against buffer A. The dialysed enzyme was subjected to isoelectric focusing in an LKB 8100 column in the pH range 3.5-10 in a 0-50% (w/v) sucrose density gradient at 1600 V for 16 h. Three peaks of GSH S-transferase activity, having pl values of 8.3, 5.5 and 4.6 (Fig. 1) , were pooled separately and dialysed against distilled water containing 1.4mM-2-mercaptoethanol.
Enzyme assays GSH S-transferase activities with different substrates were determined by using methods described by Habig et al. (1974) , Fjellstedt et al. (1973) and Keen & Jakoby (1978) . GSH peroxidase activities with cumene hydroperoxide and H202 were determined by the method of Awasthi et al. (1979) . Protein determinations were performed by the method of Bradford (1976) , with bovine serum albumin as a standard.
Electrophoretic methods
Urea / sodium dodecyl sulphate / 2-mercaptoethanol/polyacrylamide -slab-gel electrophoresis was performed by the method of Laemmli (1970) with 12.5%-polyacrylamide gels in a vertical-slabgel apparatus (LKB model 2001) . Two-dimensional gel electrophoresis was performed by the method of O'Farrell (1975) with a 10%-polyacrylamide resolving gel at 40 mA/gel. Gels were stained by the method of Cleveland et al. (1977) and de-
Amino acid analysis
Amino acid compositions were determined with a Beckman model 121 automatic amino acid analyser by the method described by Kurosky et al. (1977) .
Immunological studies
Immunodiffusion studies were performed with Ouchterlony plates (Ouchterlony, 1958) , and immunotitrations were performed as described previously (Awasthi et al., 1980) .
Results
Human brain contains significant amounts (about 3 units/g wet wt.) of GSH S-transferase activity towards l-chloro-2,4-dinitrobenzene. Upon isoelectric focusing of human brain supernatant, three peaks of GSH S-transferase activity, with pl values of 8.3, 5.5 and 4.6, were obtained. Enzyme preparations from three different brain samples exhibited similar isoelectric-focusing patterns. When grey matter and white matter of brain were spearated, the isoelectric-focusing profiles of GSH S-transferases present in both fractions were found to be similar to those obtained from whole brain.
From 200g of human brain tissue, about 200 units of purified GSH S-transferase was obtained by (NH4)2SO4 fractionation and affinity chromatography (Table 1) . Polyacrylamide-discgel electrophoresis (Davis, 1964) of this prepara- (Fig. 3d) . The less-anionic form (pI5.5) resolved into -'vo spots, both corresponding to Mr values of 2.6:00 (Fig. 3c) , whereas the cationic enzyme (pl 3.3) indicated the presence of a single spot corres.ponding to Mr 26500 (Fig. 3b) .
The amino acid compositions of the three human brain GSH S-transferases are given in Table 2 . There appear to be significant amino acid compositional differences among these forms. Most notably, the contents of serine, glycine, leucine and histidine show the maximum variation. In order to assess the amino acid composi- Dao et al. (1984) Present study Present study Present study C
Fig. 4. Double immunodiffusion of human brain GSH S-transferases
Centre wells: box A, antibodies raised against cationic GSH S-transferases of liver; box B, antibodies raised against anionic GSH S-transferase of lung; box C, antibodies raised against GSH S-transferase of placenta. Outer wells in boxes A, B and C: a, brain GSH S-transferase, pI5.5; b, brain GSH S-transferase, pI8.3; c, brain GSH Stransferase, pI4.6. Table 4 . Immunological cross-reactivities ofhuman brain GSH S-transferases with antibodies against placental, liver and lung enzymes For experimental details see the text. The subunit structures designated by Dao et al. (1984) positional differences among the three brain enzymes. Additionally, the cationic enzyme of brain (pI8.3) has significant compositional differences from the cationic enzymes of liver (Kamisaka et al., 1975) . These differences, along with the observed differences in subunit structures, indicate that the cationic enzyme of brain is different from the cationic enzymes of liver. The amino acid composition of the anionic enzyme (pI4.6) is similar to the anionic enzymes of liver, placenta and lung.
Immunological properties
Results of immunological studies obtained by immunodiffusion (Fig. 4) and immunotitration are summarized in Table 4 . The cationic GSH S-transferase (pI8.3) of brain cross-reacted with antibodies raised against the cationic GSH S-transferases of human liver, but not with the antibodies raised against the anionic GSH S-transferases of human lung or placenta. The anionic GSH S-trans- ferase (pI4.6) cross-reacted with antibodies raised against the anionic GSH S-transferases of human lung and placenta, as well as with the antibodies raised against the cationic GSH S-transferases of liver. The less-anionic enzyme (pl 5.5) did not cross-react with antibodies raised against the anionic GSH S-transferases of lung and placenta, nor with the antibodies raised against the cationic GSH S-transferases of liver, indicating that this enzyme is immunologically different from the other two enzymes of brain.
Kinetic properties
The specific activities of the three GSH S-transferases of human brain were determined towards a variety of substrates (Table 5) . I-Chloro-2,4-dinitrobenzene appears to be the preferred substrate for all three forms of brain enzyme. The anionic enzyme (pI4.6) had higher specific activities towards all of the substrates examined, except for p-nitrobenzyl chloride. The less-anionic form (pI5.5) had higher specific activity for this substrate. The cationic enzyme (pl 8.3) had much lower specific activity for most of the substrates tested, and was the only GSH S-transferase of brain that expressed GSH peroxidase activity.
Discussion
Human brain has three forms of GSH S-transferase that may provide protection to this organ from the toxic effects of a wide variety of xenobiotics. and liver (Kamisaka et al., 1975) ; however, the cationic form of brain is a dimer of 26500-Mr subunits whereas the cationic forms of liver are heterodimers of 26500-Mr and 24500-Mr subunits (Dao et al., 1982) , and the cationic form of lung is a homodimer of 24 500-Mr subunits . The enzyme form with pI5.5 also does not correspond to any previously characterized GSH S-transferase of human tissues. Even though the M, value of the subunits of this form is similar to that of the cationic enzyme of brain (pl 8.23), these two enzymes are different from each other. This is indicated by the differences in their immunological properties, amino acid compositions, catalytic properties and isoelectric points, which provide evidence for the presence of more than one type of 26 500-Mr subunit in human brain GSH S-transferases. Two-dimensional gel-electrophoresis studies reveal the presence of three charge isomers of 26 500-Mr subunits and two each of 24 500-Mr and 22 500-Mr subunits in the GSH S-transferases of human brain. The enzyme form with pI8.3 is a homodimer of 26 500-Mr subunits, and the enzyme form with pI 5.5 is a dimer of two different 26 500-Mr subunits, both of which are immunologically distinct from the 26 500-Mr subunits present in the cationic enzyme of brain. The presence of two 24 500-Mr subunits and two 22 500-Mr subunits in the more anionic form (pI4.6) raises the possibility that this form may actually be a mixture of several possible binary combinations of these four subVol. 225 units, which may not have separated during the protocol used in this study.
We have previously suggested (Dao et al., 1982 that GSH S-transferases of human liver, placenta and lung arise from the binary combinations of three different sizes of subunits designated as A (Mr 26500), B (Mr 24500) and C (Mr 22500). The present studies indicate that the brain GSH Stransferases have considerable structural and immunological similarities with the GSH S-transferases of other human tissues. Immunological cross-reactivity of the cationic enzyme of brain (pI8.3) with the cationic enzymes of liver (AB) may indicate that the 26 500-Mr subunit of the cationic enzyme of brain is similar to the A subunits of liver enzymes. The brain enzyme form with pl 5.5 is also composed of 26 500-Mr subunits, but these subunits are immunologically distinct from the A subunit of liver enzymes, and we have designated these subunits as A1 and A2 in order of increasing pl value as seen on two-dimensional gels. The immunological similarities of the pI4.6 enzyme with the anionic enzymes of placenta and lung (CC) as well as with the cationic enzymes of liver (AB) may suggest its subunit structure to be BC. More probably, this form may be a mixture of several possible dimeric combinations of two Btype and two C-type subunits. Thus brain GSH Stransferases may originate from the dimeric combination of at least five and up to seven different subunits. Three of these subunits are similar to the A, B and C subunits of liver, placental and lung enzymes. The other two subunits, AI and A2, present in the enzyme form with pl 5.5, are immunologically distinct from A and the rest of the subunits.
Heterogeneity in the similar-size subunits of rat GSH S-transferases has been described in several previous studies (Mannervik & Jensson, 1982; Frey et al., 1983; Singh et al., 1984) . The present studies for the first time provide evidence for heterogeneity in the similar-size subunits of human GSH S-transferases. The underlying structural and genetic basis for the heterogeneity in the Atype, B-type and C-type subunits of human GSH Stransferases remains obscure. Whereas these studies provide the evidence for two immunologically distinct A-type subunits, the interrelationship between AI and A2, between the two B-type subunits and that between the two C-type subunits remains to be elucidated. Deamidation in vivo of a single gene product has been suggested to be the cause of heterogeneity among the GSH S-transferases of human liver (Kamisaka et al., 1975) , and it might be tempting to suggest that the charge heterogeneity seen among the subunits of human brain GSH S-transferases could arise by this process. However, the existence of at least two immunologically distinct A-type subunits in brain GSH S-transferases clearly indicates that deamidation in vivo alone cannot explain this heterogeneity.
